| Product Code: ETC9970769 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Molecular Diagnostics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Molecular Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Molecular Diagnostics Market - Industry Life Cycle |
3.4 United States (US) Molecular Diagnostics Market - Porter's Five Forces |
3.5 United States (US) Molecular Diagnostics Market Revenues & Volume Share, By Product & Services, 2021 & 2031F |
3.6 United States (US) Molecular Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 United States (US) Molecular Diagnostics Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.8 United States (US) Molecular Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 United States (US) Molecular Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Molecular Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases and chronic conditions driving demand for molecular diagnostics. |
4.2.2 Technological advancements leading to the development of more advanced and accurate molecular diagnostic tests. |
4.2.3 Rising awareness about personalized medicine driving the adoption of molecular diagnostics. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and lengthy approval processes can hinder market growth. |
4.3.2 High costs associated with molecular diagnostic tests may limit accessibility, especially in lower-income populations. |
5 United States (US) Molecular Diagnostics Market Trends |
6 United States (US) Molecular Diagnostics Market, By Types |
6.1 United States (US) Molecular Diagnostics Market, By Product & Services |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Molecular Diagnostics Market Revenues & Volume, By Product & Services, 2021- 2031F |
6.1.3 United States (US) Molecular Diagnostics Market Revenues & Volume, By Kits, 2021- 2031F |
6.1.4 United States (US) Molecular Diagnostics Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.5 United States (US) Molecular Diagnostics Market Revenues & Volume, By Software, 2021- 2031F |
6.2 United States (US) Molecular Diagnostics Market, By Test Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Molecular Diagnostics Market Revenues & Volume, By Lab, 2021- 2031F |
6.2.3 United States (US) Molecular Diagnostics Market Revenues & Volume, By PoC, 2021- 2031F |
6.3 United States (US) Molecular Diagnostics Market, By Sample |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Molecular Diagnostics Market Revenues & Volume, By Blood, 2021- 2031F |
6.3.3 United States (US) Molecular Diagnostics Market Revenues & Volume, By Urine, 2021- 2031F |
6.4 United States (US) Molecular Diagnostics Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Molecular Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F |
6.4.3 United States (US) Molecular Diagnostics Market Revenues & Volume, By NGS, 2021- 2031F |
6.4.4 United States (US) Molecular Diagnostics Market Revenues & Volume, By ISH, 2021- 2031F |
6.4.5 United States (US) Molecular Diagnostics Market Revenues & Volume, By INAAT, 2021- 2031F |
6.5 United States (US) Molecular Diagnostics Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Molecular Diagnostics Market Revenues & Volume, By Infectious, 2021- 2031F |
6.5.3 United States (US) Molecular Diagnostics Market Revenues & Volume, By Oncology, 2021- 2031F |
7 United States (US) Molecular Diagnostics Market Import-Export Trade Statistics |
7.1 United States (US) Molecular Diagnostics Market Export to Major Countries |
7.2 United States (US) Molecular Diagnostics Market Imports from Major Countries |
8 United States (US) Molecular Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of molecular diagnostic tests by healthcare providers. |
8.2 Number of research and development partnerships for developing new molecular diagnostic technologies. |
8.3 Rate of integration of molecular diagnostics into routine clinical practice. |
8.4 Number of publications and studies highlighting the clinical utility of molecular diagnostics. |
8.5 Patient outcomes improvement metrics associated with the use of molecular diagnostics. |
9 United States (US) Molecular Diagnostics Market - Opportunity Assessment |
9.1 United States (US) Molecular Diagnostics Market Opportunity Assessment, By Product & Services, 2021 & 2031F |
9.2 United States (US) Molecular Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.3 United States (US) Molecular Diagnostics Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.4 United States (US) Molecular Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 United States (US) Molecular Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Molecular Diagnostics Market - Competitive Landscape |
10.1 United States (US) Molecular Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Molecular Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here